Does the age affect the efficacy of angiogenesis inhibitors in ovarian cancer? A meta-analysis of randomized controlled trials.

@article{Miao2017DoesTA,
  title={Does the age affect the efficacy of angiogenesis inhibitors in ovarian cancer? A meta-analysis of randomized controlled trials.},
  author={Hui Miao and C Miao and J H Han and N Li},
  journal={European review for medical and pharmacological sciences},
  year={2017},
  volume={21 13},
  pages={
          3047-3053
        }
}
  • Hui Miao, C Miao, +1 author N Li
  • Published 2017 in
    European review for medical and pharmacological…
OBJECTIVE There are limited data on the role of angiogenesis inhibitors (AIs) in the treatment of elderly patients with ovarian cancer. We aim to assess the overall efficacy of AIs-containing regimens in the treatment of ovarian cancer in this patients group. MATERIALS AND METHODS Databases and abstracts presented meetings up to November 2016 were searched to identify relevant studies. Prospective randomized controlled trials (RCTs) investigating therapies with or without AIs in elderly… CONTINUE READING